The Hong Kong Securities and Futures Commission directed the Stock Exchange of Hong Kong to suspend trading in Cloudbreak Pharma Inc. shares from 9 a.m. over serious concerns that the company’s initial public offering may have been rigged to create an artificial impression of demand. The suspension will remain in place while the commission investigates the matter. The regulator considers the action necessary to maintain an orderly and fair market and protect investors. Cloudbreak has been listed on the exchange’s Main Board since July 3, 2025.
2026-09-10Hong Kong Securities & Futures Commission
Hong Kong Securities and Futures Commission directs suspension of Cloudbreak Pharma shares over suspected IPO rigging
The Hong Kong Securities and Futures Commission directed the suspension of trading in Cloudbreak Pharma shares from 9 a.m. over concerns that its initial public offering may have been rigged to create artificial demand. The suspension will apply while the regulator’s investigation continues.